摘要
Three new lanthanide complexes with the formulae [Eu2（TsGly）6（phen）2（H2O）2] （1）, [Ln（TsGly）2（phen）2-（H2O）2]C1·2H2O [Ln=Er（2a） and Yb （2b）, TsGly=N-p-tolylsulfonylglycinate, phen= 1,10-phenanthroline] were synthesized. Crystallographic data for 1： monoclinic, P21/n, a= 1.29791（16） nm, b= 1.9034（2） nm, c= 1.7596（2） nm,β=93.410（3）°, V=4.3394（9） nm^3, Z=4, R1 =0.0326, wR2=0.0771; and for 2b： triclinic, P1, a= 1.2674（2） nm, b= 1.4405（2） nm, c= 1.4809（3） nm, a= 113.256（3）°, β= 108.253（3）°, γ=94.739（3）°, V=2.2922（7） nm°3, Z=2, R1=0.0292, wR2=0.0669. X-ray diffractional analysis reveals that compound 1 adopts dinuclear structure with fourfold bridging TsGly ligands between the Eu（Ⅲ） centers, while compound 2b features an unusual mononuclear structure.
Three new lanthanide complexes with the formulae [Eu2（TsGly）6（phen）2（H2O）2] （1）, [Ln（TsGly）2（phen）2-（H2O）2]C1·2H2O [Ln=Er（2a） and Yb （2b）, TsGly=N-p-tolylsulfonylglycinate, phen= 1,10-phenanthroline] were synthesized. Crystallographic data for 1： monoclinic, P21/n, a= 1.29791（16） nm, b= 1.9034（2） nm, c= 1.7596（2） nm,β=93.410（3）°, V=4.3394（9） nm^3, Z=4, R1 =0.0326, wR2=0.0771; and for 2b： triclinic, P1, a= 1.2674（2） nm, b= 1.4405（2） nm, c= 1.4809（3） nm, a= 113.256（3）°, β= 108.253（3）°, γ=94.739（3）°, V=2.2922（7） nm°3, Z=2, R1=0.0292, wR2=0.0669. X-ray diffractional analysis reveals that compound 1 adopts dinuclear structure with fourfold bridging TsGly ligands between the Eu（Ⅲ） centers, while compound 2b features an unusual mononuclear structure.
基金
Project supported by Guangxi Provincial Education Foundation of China and Natural Science Foundation of Guangxi Province （No. 0229004）.
